Prospera Financial Services Inc Sells 1,028 Shares of Intuitive Surgical, Inc. $ISRG

Prospera Financial Services Inc lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,653 shares of the medical equipment provider’s stock after selling 1,028 shares during the period. Prospera Financial Services Inc’s holdings in Intuitive Surgical were worth $11,224,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in ISRG. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. raised its holdings in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares in the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the period. Wellington Management Group LLP increased its position in shares of Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC acquired a new position in Intuitive Surgical in the first quarter valued at about $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $560.00 on Friday. The firm has a 50 day moving average price of $471.89 and a two-hundred day moving average price of $500.87. The stock has a market cap of $200.75 billion, a P/E ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 98,078 shares of company stock valued at $51,445,892 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Sanford C. Bernstein reiterated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Piper Sandler upped their target price on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. HSBC lifted their price target on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.